UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Are Results From Intermediate-Risk Prostate Cancer Patients Treated Within Clinical Trials Applicable to Real Life?

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E243-E243

2015

Link zum Volltext

Verfügbarkeit prüfen

N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

International journal of radiation oncology, biology, physics, 2016-12, Vol.96 (5), p.937-937

2016

Link zum Volltext

Verfügbarkeit prüfen

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

International journal of radiation oncology, biology, physics, 2016, Vol.94 (1), p.3-3

2016

Link zum Volltext

Verfügbarkeit prüfen

Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

International journal of radiation oncology, biology, physics, 2016, Vol.94 (1), p.2-2

2016

Link zum Volltext

Verfügbarkeit prüfen

Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S199-S200

2015

Link zum Volltext

Verfügbarkeit prüfen

Acute and Late Urinary Toxicity After Radiation Therapy in Men With and Without an Intact Prostate Gland: A Secondary Analysis of RTOG 9408 and 9601 Suggesting This Toxicity is Not Due to Bladder Injury

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S14-S14

2012

Link zum Volltext

Verfügbarkeit prüfen

PO-0678 HYPOFRACTIONATION WITH ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER: RESULTS AT 8 YEARS

Radiotherapy and oncology, 2012-05, Vol.103, p.S264-S264

2012

Link zum Volltext

Verfügbarkeit prüfen

1044 poster THE IMPACT OF ANTI-COAGULANTS AND STATINS ON PROSTATE CANCER

Radiotherapy and oncology, 2011, Vol.99, p.S389-S389

2011

Link zum Volltext

Verfügbarkeit prüfen

Symptomatic Posttreatment Edema after Stereotactic Radiotherapy for Intracranial Meningiomas: Patterns and Predictive Factors

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e85-e85

2023

Link zum Volltext

Verfügbarkeit prüfen

Active Surveillance before Radiotherapy — Outcome and Predictive Factors for Multiple Biopsies before Treatment

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e890-e890

2020

Link zum Volltext

Verfügbarkeit prüfen

536 oral RTOG 9601: SALVAGE RT & ANTI-ANDROGEN THERAPY IN PROSTATE CANCER PATIENTS WITH ELEVATED PSA AFTER SURGERY

Radiotherapy and oncology, 2011, Vol.99, p.S219-S219

2011

Link zum Volltext

Verfügbarkeit prüfen

Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1254-1259

2000

Link zum Volltext

Verfügbarkeit prüfen

Patient Reported Outcomes in High-Risk Prostate Cancer Patients with or without Testosterone Recovery after Androgen Deprivation Therapy

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.S95-S96

2023

Link zum Volltext

Verfügbarkeit prüfen

139 poster: Brachytherapy in the Province of Quebec: A Pattern of Use Study

Radiotherapy and oncology, 2009-05, Vol.91, p.S50-S51

2009

Link zum Volltext

Verfügbarkeit prüfen

A0601 - Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials

European urology, 2024-03, Vol.85, p.S1513-S1513

2024

Link zum Volltext

Verfügbarkeit prüfen

Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials

European urology, 2024-03, Vol.85, p.S1513

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.S4-S5

2023

Link zum Volltext

Verfügbarkeit prüfen

Patterns of Failure after Stereotactic Radiosurgery vs. Whole Brain Radiotherapy for Resected Brain Metastases: Central Imaging Review of the N107C/CEC.3 (Alliance) Phase III Clinical Trial

International journal of radiation oncology, biology, physics, 2022-12, Vol.114 (5), p.1063-1064

2022

Link zum Volltext

Verfügbarkeit prüfen

Combined Risk Factors and Outcomes in High-Risk Prostate Cancer: Secondary Analysis of a Phase III Trial

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e233-e234

2022

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Causes of Death in Patients Treated for Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e234

2022

Link zum Volltext

Verfügbarkeit prüfen

Outcomes Comparison Using PSA Cut-Off Values Of 0.1 Or 0.2 Ng/Ml At 6 Months In Localized High-Risk Prostate Cancer Treated With Androgen Deprivation Therapy And Radiotherapy: Prospective Data From A Phase III Trial

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e855-e855

2020

Link zum Volltext

Verfügbarkeit prüfen

Body Composition and Risk of All-Cause Mortality in Men Treated With Radiation Therapy for Prostate Cancer: A Pooled Analysis of NRG/RTOG 9406 and NRG/RTOG 0126

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e285-e286

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors in Radium-223 Treatment—An Early Canadian Single-Center Experience

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.E226-E227

2017

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multi-Modal Deep Learning with Digital Histopathology

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.S2

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Photon and Proton Radiotherapy Plan Quality With the Knowledge-Based Approach in NRG BN001 Clinical Trial

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e344-e345

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

ThemaBrain Neoplasms - Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(54)

Sprache

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(10)
Life Sciences & Biomedicine
(6)
Radiology
(6)
Science & Technology
(6)
Biological And Medical Sciences
(4)
Medical Sciences
(4)
Clinical Neurology
(3)
Humans
(3)
Middle Aged
(3)
Neurosciences & Neurology
(3)
Oncology
(3)
Aged
(2)
Female
(2)
Male
(2)
Original
(2)
Pharmacology. Drug Treatments
(2)
Radiology, Nuclear Medicine & Medical Imaging
(2)
Abdomen
(1)
Abdominal Fat
(1)
Adipose Tissue
(1)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Are Results From Intermediate-Risk Prostate Cancer Patients Treated Within Clinical Trials Applicable to Real Life?

N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer

Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer

Acute and Late Urinary Toxicity After Radiation Therapy in Men With and Without an Intact Prostate Gland: A Secondary Analysis of RTOG 9408 and 9601 Suggesting This Toxicity is Not Due to Bladder Injury

PO-0678 HYPOFRACTIONATION WITH ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER: RESULTS AT 8 YEARS

1044 poster THE IMPACT OF ANTI-COAGULANTS AND STATINS ON PROSTATE CANCER

Symptomatic Posttreatment Edema after Stereotactic Radiotherapy for Intracranial Meningiomas: Patterns and Predictive Factors

Active Surveillance before Radiotherapy — Outcome and Predictive Factors for Multiple Biopsies before Treatment

536 oral RTOG 9601: SALVAGE RT & ANTI-ANDROGEN THERAPY IN PROSTATE CANCER PATIENTS WITH ELEVATED PSA AFTER SURGERY

Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme

Patient Reported Outcomes in High-Risk Prostate Cancer Patients with or without Testosterone Recovery after Androgen Deprivation Therapy

139 poster: Brachytherapy in the Province of Quebec: A Pattern of Use Study

A0601 - Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials

Incidence of cardiovascular death in localized prostate cancer and its relationship to androgen blockade: Long-term data from two phase III trials

Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer

Patterns of Failure after Stereotactic Radiosurgery vs. Whole Brain Radiotherapy for Resected Brain Metastases: Central Imaging Review of the N107C/CEC.3 (Alliance) Phase III Clinical Trial

Combined Risk Factors and Outcomes in High-Risk Prostate Cancer: Secondary Analysis of a Phase III Trial

Cardiovascular Causes of Death in Patients Treated for Localized Prostate Cancer

Outcomes Comparison Using PSA Cut-Off Values Of 0.1 Or 0.2 Ng/Ml At 6 Months In Localized High-Risk Prostate Cancer Treated With Androgen Deprivation Therapy And Radiotherapy: Prospective Data From A Phase III Trial

Body Composition and Risk of All-Cause Mortality in Men Treated With Radiation Therapy for Prostate Cancer: A Pooled Analysis of NRG/RTOG 9406 and NRG/RTOG 0126

Prognostic Factors in Radium-223 Treatment—An Early Canadian Single-Center Experience

Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multi-Modal Deep Learning with Digital Histopathology

Evaluation of Photon and Proton Radiotherapy Plan Quality With the Knowledge-Based Approach in NRG BN001 Clinical Trial

Aktive Filter

Suchergebnisse filtern